Comparison of demineralized bone matrix and hydroxyapatite as carriers of Escherichia coli recombinant human BMP-2

[1]  Jong-Keon Oh,et al.  Review of bone graft and bone substitutes with an emphasis on fracture surgeries , 2019, Biomaterials Research.

[2]  Jae Hyup Lee,et al.  Escherichia coli BMP-2 showed comparable osteoinductivity with Chinese hamster ovary derived BMP-2 with demineralized bone matrix as carrier , 2019, Growth factors.

[3]  S. Märdian,et al.  Anabolic Therapies in Osteoporosis and Bone Regeneration , 2018, International journal of molecular sciences.

[4]  H. Wong,et al.  A Computed Tomography Analysis of the Success of Spinal Fusion Using Ultra-Low Dose (0.7 mg per Facet) of Recombinant Human Bone Morphogenetic Protein 2 in Multilevel Adult Degenerative Spinal Deformity Surgery , 2018, Asian spine journal.

[5]  Jae Hyup Lee,et al.  Mesenchymal Stem Cell Therapy for Bone Regeneration , 2018, Clinics in orthopedic surgery.

[6]  D. Hutmacher,et al.  Animal models for bone tissue engineering and modelling disease , 2018, Disease Models & Mechanisms.

[7]  Jae-Jun Yang,et al.  Efficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial. , 2017, The spine journal : official journal of the North American Spine Society.

[8]  V. Agrawal,et al.  A review on carrier systems for bone morphogenetic protein-2. , 2017, Journal of biomedical materials research. Part B, Applied biomaterials.

[9]  G. Duda,et al.  * Demineralized Bone Matrix as a Carrier for Bone Morphogenetic Protein-2: Burst Release Combined with Long-Term Binding and Osteoinductive Activity Evaluated In Vitro and In Vivo. , 2017, Tissue engineering. Part A.

[10]  Seong-Ho Choi,et al.  Bone Regenerative Efficacy of Limited-Dose Escherichia Coli–Derived rhBMP-2 With Biphasic Calcium Phosphate Carrier in Rabbit Calvarial Defect Model , 2016, Implant dentistry.

[11]  Seong-Ho Choi,et al.  Rapid bone regeneration by Escherichia coli-derived recombinant human bone morphogenetic protein-2 loaded on a hydroxyapatite carrier in the rabbit calvarial defect model , 2015, Biomaterials Research.

[12]  H. Le,et al.  Mechanical property and biocompatibility of co-precipitated nano hydroxyapatite–gelatine composites , 2015, Journal of Advanced Ceramics.

[13]  Byung-Soo Kim,et al.  Controlled release of BMP-2 using a heparin-conjugated carrier system reduces in vivo adipose tissue formation. , 2015, Journal of biomedical materials research. Part A.

[14]  P. Touzopoulos,et al.  Use of demineralized bone matrix in spinal fusion. , 2014, World journal of orthopedics.

[15]  E. Park,et al.  Comparison of bone regeneration rate in flat and long bone defects: Calvarial and tibial bone , 2013, Tissue Engineering and Regenerative Medicine.

[16]  K. Lee,et al.  Effects of porous beta-tricalcium phosphate-based ceramics used as an E. coli-derived rhBMP-2 carrier for bone regeneration , 2013, Journal of Materials Science: Materials in Medicine.

[17]  J. Jansen,et al.  Evaluation of bone regeneration using the rat critical size calvarial defect , 2012, Nature Protocols.

[18]  D. Grainger,et al.  Demineralized bone matrix as a vehicle for delivering endogenous and exogenous therapeutics in bone repair. , 2012, Advanced drug delivery reviews.

[19]  J. Hollinger,et al.  Demineralized bone matrix in bone repair: History and use☆ , 2012, Advanced Drug Delivery Reviews.

[20]  Ivan Wall,et al.  Administration of growth factors for bone regeneration. , 2012, Regenerative medicine.

[21]  Jae-Jun Yang,et al.  Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier. , 2012, The spine journal : official journal of the North American Spine Society.

[22]  Byung-Soo Kim,et al.  Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration , 2012, Experimental & Molecular Medicine.

[23]  Sang‐Wan Shin,et al.  Randomized clinical trial on the efficacy of Escherichia coli-derived rhBMP-2 with β-TCP/HA in extraction socket , 2011, The journal of advanced prosthodontics.

[24]  N. Haas,et al.  Quantification of various growth factors in different demineralized bone matrix preparations. , 2007, Journal of biomedical materials research. Part A.

[25]  Jeffrey C. Wang,et al.  Demineralized bone matrix and spinal arthrodesis. , 2005, The spine journal : official journal of the North American Spine Society.

[26]  A. Hasharoni,et al.  Use of hydroxyapatite in spine surgery , 2001, European Spine Journal.

[27]  J. Dai,et al.  An effective delivery vehicle of demineralized bone matrix incorporated with engineered collagen-binding human bone morphogenetic protein-2 to accelerate spinal fusion at low dose , 2017, Journal of Materials Science: Materials in Medicine.

[28]  Y. Tabata,et al.  BMP-2 release and dose-response studies in hydroxyapatite and beta-tricalcium phosphate. , 2009, Bio-medical materials and engineering.

[29]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..